OSTX Stock Analysis: Buy, Sell, or Hold?
OSTX - OS Therapies Incorporated
$1.69
0.06 (4.01%)
▲
5d:
+5.97%
30d:
-1.46%
90d:
+27.65%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 17, 2026
Get Alerted When OSTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called OSTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: OSTX shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: OSTX shows positive signals but monitor for confirmation. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$10.09
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$6.26
73.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSTX is currently trading at $1.69, which is considered oversold relative to its 30-day fair value range of $1.65 to $1.92.
Technical Outlook: Technically, OSTX is in a uptrend. The price is currently testing key support at $1.71. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: OSTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.92 (+450.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OSTX is in a uptrend. The price is currently testing key support at $1.71. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: OSTX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.92 (+450.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.65 -
$1.92
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 450.5% below Wall St target ($8.92)
Trading Range Analysis
30-Day Trading Range
$1.65 -
$1.92
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.71
Resistance Level
$2.20
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.50
Wall Street Target
$8.92
(+450.5%)
Share & Embed Analysis
Last updated: July 14, 2026 12:19 PM ET
Data refreshes hourly during market hours. Next update: 1:19 PM
Data refreshes hourly during market hours. Next update: 1:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 61 BUY |
